Inventor · disambiguated record
Werner Cautreels
Also filed as: CAUTREELS WERNER · CAUTREELS WERNER L M
4 granted patents·6 pending applications·39 citations·filing 1983–2024
73Inventor score
Top patents by PatentIndex Score
10 records- 0175US2025057756A1Formulations and doses of pegylated uricaseCARTESIAN THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0275US2025090451A1Formulations and doses of pegylated uricaseCARTESIAN THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0374US4721710ADerivatives of piperidinedione for protecting the myocardium presenting an anti-arrythmic activity, and pharmaceutical compositionsSANOFI SA·Filed 1986·Granted Jan 26, 1988·24 cites·9 claims
- 0473US6566369B2Medicament containing cilansetron for the treatment of non-obstipative male irritable bowel syndrome patientsSOLVAY PHARM GMBH·Filed 2001·Granted May 20, 2003·12 cites·3 claims
- 0567US7087620B2Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1]nonane compounds and methods of treatment relating to anti-arrhythmic eventsSOLVAY PHARM GMBH·Filed 2003·Granted Aug 8, 2006·3 cites·17 claims
- 0648US2005054667A1Method of treating or inhibiting anti-arrhythmic events in male human patientsSOLVAY PHARM GMBH·Filed 2004·Application pending·0 cites
- 0747US2003125349A1Medicament containing cilansetron for the treatment of non-obstipative male irritable bowel syndrome patientsSOLVAY PHARM GMBH·Filed 2003·Application pending·0 cites
- 0844US2005261300A1Liquid pharmaceutical formulations containing 3.7-diazabicyclo[3,3,1]nonane compounds and methods of treatment relating to arrhythmic eventsSOLVAY PHARM GMBH·Filed 2005·Application pending·0 cites
- 0942US2021187081A1Formulations and doses of pegylated uricaseSELECTA BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1027US4542134ADerivatives of γ-butyrolactone with an anti-arrythmic activity and compositionsSANOFI SA·Filed 1983·Granted Sep 17, 1985·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Werner Cautreels files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →